Cancer Prognoses Informed by Module-Based Approach, Study Finds
Researchers highlight patient survival and other prognostic clues that can be drawn from expression data and related module-based molecular analyses on several cancer types.
Gastric Cancer Chemotherapy Response, Prognoses Predicted With Blood-Based Immune Proteomics
By analyzing blood serum proteomics alongside gastric tumors' omics profiles, researchers found immune features coinciding with treatment response and survival.
The assay underwent clinical validation at three centers in Singapore and 5,248 patients were ultimately screened using the test.
Wales to Routinely Screen Cancer Patients With Yourgene Elucigene Test
Yourgene will provide its Elucigene DPYD tests to screen approximately 200 patients each month for the next year.
Exact Sciences Stock Soars on New Data Around Pan-Cancer Liquid Biopsy Test
The firm presented initial study results from the test, which identifies six cancers, showing overall sensitivity at 86 percent and specificity of 95 percent.